Search by Drug Name or NDC

    NDC 70000-0465-01 Leader Maximum Strength Mucus Relief DM 20; 400 mg/20mL; mg/20mL Details

    Leader Maximum Strength Mucus Relief DM 20; 400 mg/20mL; mg/20mL

    Leader Maximum Strength Mucus Relief DM is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by CARDINAL HEALTH 110, LLC. DBA LEADER. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.

    Product Information

    NDC 70000-0465
    Product ID 70000-0465_a339e9ce-bc00-4467-ad90-d8cb333ee0a7
    Associated GPIs 43997002520905
    GCN Sequence Number 023893
    GCN Sequence Number Description guaifenesin/dextromethorphan LIQUID 100-5 MG/5 ORAL
    HIC3 B3T
    HIC3 Description NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION
    GCN 53497
    HICL Sequence Number 000223
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR
    Brand/Generic Generic
    Proprietary Name Leader Maximum Strength Mucus Relief DM
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextromethorphan HBr, Guaifenesin
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 20; 400
    Active Ingredient Units mg/20mL; mg/20mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
    Labeler Name CARDINAL HEALTH 110, LLC. DBA LEADER
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2023-12-31

    Package

    NDC 70000-0465-01 (70000046501)

    NDC Package Code 70000-0465-1
    Billing NDC 70000046501
    Package 177 mL in 1 BOTTLE (70000-0465-1)
    Marketing Start Date 2019-07-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.01972
    Pricing Unit ML
    Effective Date 2022-07-20
    NDC Description MUCUS RELIEF DM MAX LIQUID
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2022-08-31
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 22efdf17-92c7-4670-8470-4f99d24ce7de Details

    Revised: 1/2022